94 related articles for article (PubMed ID: 8180805)
1. Dopamine uptake sites in Parkinson's disease and in dementia of the Alzheimer type.
Allard PO; Rinne J; Marcusson JO
Brain Res; 1994 Feb; 637(1-2):262-6. PubMed ID: 8180805
[TBL] [Abstract][Full Text] [Related]
2. Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer's disease.
Allard P; Alafuzoff I; Carlsson A; Eriksson K; Ericson E; Gottfries CG; Marcusson JO
Eur Neurol; 1990; 30(4):181-5. PubMed ID: 2209670
[TBL] [Abstract][Full Text] [Related]
3. Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen.
Allard P; Marcusson JO
Neurobiol Aging; 1989; 10(6):661-4. PubMed ID: 2628776
[TBL] [Abstract][Full Text] [Related]
4. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Burn D; Johnson M; Perry RH; McKeith IG; Ballard C; Perry EK
Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
[TBL] [Abstract][Full Text] [Related]
5. [3H]GBR 12935 binding to dopamine uptake sites: subcellular localization and reduction in Parkinson's disease and progressive supranuclear palsy.
Maloteaux JM; Vanisberg MA; Laterre C; Javoy-Agid F; Agid Y; Laduron PM
Eur J Pharmacol; 1988 Nov; 156(3):331-40. PubMed ID: 3215281
[TBL] [Abstract][Full Text] [Related]
6. [3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease.
Janowsky A; Vocci F; Berger P; Angel I; Zelnik N; Kleinman JE; Skolnick P; Paul SM
J Neurochem; 1987 Aug; 49(2):617-21. PubMed ID: 3598589
[TBL] [Abstract][Full Text] [Related]
7. Autoradiographic study on dopamine uptake sites and their correlation with dopamine levels and their striata from patients with Parkinson disease, Alzheimer disease, and neurologically normal controls.
Mizukawa K; McGeer EG; McGeer PL
Mol Chem Neuropathol; 1993; 18(1-2):133-44. PubMed ID: 8466587
[TBL] [Abstract][Full Text] [Related]
8. A post-mortem study on striatal dopamine receptors in Parkinson's disease.
Rinne JO; Laihinen A; Lönnberg P; Marjamäki P; Rinne UK
Brain Res; 1991 Aug; 556(1):117-22. PubMed ID: 1834312
[TBL] [Abstract][Full Text] [Related]
9. [3H]GBR-12935 binding to dopamine uptake sites in the human brain.
Marcusson J; Eriksson K
Brain Res; 1988 Aug; 457(1):122-9. PubMed ID: 3167558
[TBL] [Abstract][Full Text] [Related]
10. [3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics.
Hirai M; Kitamura N; Hashimoto T; Nakai T; Mita T; Shirakawa O; Yamadori T; Amano T; Noguchi-Kuno SA; Tanaka C
Jpn J Pharmacol; 1988 Jul; 47(3):237-43. PubMed ID: 3221529
[TBL] [Abstract][Full Text] [Related]
11. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.
Wilson JM; Levey AI; Rajput A; Ang L; Guttman M; Shannak K; Niznik HB; Hornykiewicz O; Pifl C; Kish SJ
Neurology; 1996 Sep; 47(3):718-26. PubMed ID: 8797470
[TBL] [Abstract][Full Text] [Related]
12. Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia.
Pearce RK; Seeman P; Jellinger K; Tourtellotte WW
Eur Neurol; 1990; 30 Suppl 1():9-14. PubMed ID: 2138080
[TBL] [Abstract][Full Text] [Related]
13. Decreased densities of dopamine D1 receptors in the putamen and hippocampus in senile dementia of the Alzheimer type.
Cortés R; Probst A; Palacios JM
Brain Res; 1988 Dec; 475(1):164-7. PubMed ID: 2975188
[TBL] [Abstract][Full Text] [Related]
14. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
[TBL] [Abstract][Full Text] [Related]
15. Decrease in [3H]cocaine binding to the dopamine transporter in Parkinson's disease.
Pimoule C; Schoemaker H; Javoy-Agid F; Scatton B; Agid Y; Langer SZ
Eur J Pharmacol; 1983 Nov; 95(1-2):145-6. PubMed ID: 6667712
[No Abstract] [Full Text] [Related]
16. Altropane, a SPECT or PET imaging probe for dopamine neurons: III. Human dopamine transporter in postmortem normal and Parkinson's diseased brain.
Madras BK; Gracz LM; Fahey MA; Elmaleh D; Meltzer PC; Liang AY; Stopa EG; Babich J; Fischman AJ
Synapse; 1998 Jun; 29(2):116-27. PubMed ID: 9593102
[TBL] [Abstract][Full Text] [Related]
17. Function of sigma1 receptors in Parkinson's disease.
Mishina M; Ishiwata K; Ishii K; Kitamura S; Kimura Y; Kawamura K; Oda K; Sasaki T; Sakayori O; Hamamoto M; Kobayashi S; Katayama Y
Acta Neurol Scand; 2005 Aug; 112(2):103-7. PubMed ID: 16008536
[TBL] [Abstract][Full Text] [Related]
18. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
19. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
Allard PO; Eriksson K; Ross SB; Marcusson JO
Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
[TBL] [Abstract][Full Text] [Related]
20. Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
Lehéricy S; Brandel JP; Hirsch EC; Anglade P; Villares J; Scherman D; Duyckaerts C; Javoy-Agid F; Agid Y
Brain Res; 1994 Oct; 659(1-2):1-9. PubMed ID: 7820649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
